Evidence map›Paper›PMID 25122866›Full record

ArticleJournal of clinical microbiology2014

Clinical characteristics of patients who test positive for Clostridium difficile by repeat PCR.

Daniel A Green, Brie Stotler, Dana Jackman, Susan Whittier, Phyllis Della-Latta

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Diagnostic Guidance for C. difficile Infections.Advances in experimental medicine and biology · 2024
    Article
  3. The Role of Diagnostic Stewardship inCurrent infectious disease reports · 2020
    Article
  4. Current knowledge on the laboratory diagnosis ofWorld journal of gastroenterology · 2017
    Review
  5. Article
  6. Diagnostic yield of repeat sampling with immunoassay, real-time PCR, and toxigenic culture for the detection of toxigenic Clostridium difficile in an epidemic and a non-epidemic setting.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2015
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daniel A GreenDepartment of Pathology and Cell Biology, Columbia University College of Physicians and Surgeons, New York, New York, USA dag2149@columbia.edu.
Brie StotlerDepartment of Pathology and Cell Biology, Columbia University College of Physicians and Surgeons, New York, New York, USA.
Dana JackmanClinical Microbiology Service, Columbia University Medical Center, New York-Presbyterian Hospital, New York, New York, USA.
Susan WhittierDepartment of Pathology and Cell Biology, Columbia University College of Physicians and Surgeons, New York, New York, USA Clinical Microbiology Service, Columbia University Medical Center, New York-Presbyterian Hospital, New York, New York, USA.
Phyllis Della-LattaDepartment of Pathology and Cell Biology, Columbia University College of Physicians and Surgeons, New York, New York, USA Clinical Microbiology Service, Columbia University Medical Center, New York-Presbyterian Hospital, New York, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high sensitivity of PCR assays for diagnosing Clostridium difficile infection (CDI) has greatly reduced the need for repeat testing after a negative result. Nevertheless, a small subset of patients do test positive within 7 days of a negative test. The aim of this study was to evaluate the clinical characteristics of these patients to determine when repeat testing may be appropriate. The results of all Xpert C. difficile PCR (Cepheid, Sunnyvale CA) tests performed in the clinical microbiology laboratory at New York-Presbyterian Hospital, Columbia University Medical Center (NYPH/CUMC) from 1 May 2011 through 6 September 2013, were reviewed. A retrospective case-control study was performed, comparing patients who tested positive within 7 days of a negative test result to a random selection of 50 controls who tested negative within 7 days of a negative test result. During the study period, a total of 14,875 tests were performed, of which 1,066 were repeat tests (7.2%). Eleven of these repeat tests results were positive (1.0%). The only risk factor independently associated with repeat testing positive was history of a prior CDI (odds ratio [OR], 19.6 [95% confidence interval {CI}, 4.0 to 19.5], P < 0.001). We found that patients who test positive for C. difficile by PCR within 7 days of a negative test are more likely to have a history of CDI than are patients who test negative with repeat PCR. This finding may be due to the high rate of disease relapse or the increased likelihood of empirical therapy leading to false-negative results in these patients.

Indexed as

Academic Medical CentersCase-Control StudiesClostridioides difficileClostridium InfectionsFemaleHumansMaleMiddle AgedNew York CityPolymerase Chain ReactionRetrospective StudiesRisk Factors

Identifiers

PMID25122866
PMCPMC4313214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.